Physician profile
Daniel S Blue
NPI 1841434461
$3,312.35
in general payments reported to CMS, 2019-2025
10 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $310 · 2021: $298 · 2022: $380 · 2023: $1,634 · 2024: $61.22 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,193 · Entertainment: $500 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,192.76 |
| Entertainment | $500.00 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,462.50 | 2023 | |
| Align Technology, INC. | $746.21 | 2019-2025 | Invisalign, Itero Element 5d Plus, Other |
| Lightforce Orthodontics, INC. | $240.05 | 2022 | |
| Ormco Corporation | $211.08 | 2019-2023 | Damon |
| Ortho Organizers, INC. | $158.84 | 2019-2022 | |
| Envista Holdings Corporation | $147.52 | 2024-2025 | Ortho Solo, Spark, Damon |
| World Class Technology Corporation | $145.88 | 2019 | |
| USA Angelalign Technology Corp | $73.68 | 2025 | |
| Nobel Biocare USA | $69.90 | 2023 | Nobelactive |
| American Orthodontics Corporation | $56.69 | 2024-2025 | Master Series, Lp and Ifit Tubes, Radiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Blue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.